ZFC3H1 and pulmonary arterial hypertension: The mechanism by which ZFC3H1 promotes the expression of its targets in PAH is of high relevance, as ZFC3H1 is known to lead to mRNA degradation as part of the poly(A) tail exosome targeting (PAXT) connection [47,48].